D5.4 Production of JCA on medicinal products and medical devices
This EUnetHTA 21 deliverable (D5.4) focusses on the planned clinical assessments during EUnetHTA 21, in accordance with the tender specifications.
The objectives of this deliverable are to:
- Produce JCA for medicinal products (at least 1, maximum 2) and medical devices (at least 2, maximum 4), to continue to improve quality, consistency and national uptake of the JCA and further standardize the production process.
- During the JCA production, test the methodological convergence paths defined at the end of EUnetHTA JA3 (i.e. PICO concept paper and the GRADE framework paper).
- During the JCA production, test the new methodological guidelines that will be developed by EUnetHTA 21 as well as the revised templates and guidelines, responding to identified challenges in EUnetHTA JA3.
For any questions regarding this deliverable, please contact JCA_Secretariat@zinl.nl
Below you can find the published documentation:
|
D5.4 Production of JCA/CA on medicinal products and medical devices – Project Plan JCAMD001 – [to be published in June 2023] |
